Marfan Syndrome and Myocardial Infarction from Atherosclerosis
Marfan syndrome does not directly cause myocardial infarction through atherosclerotic mechanisms, but MI can occur as a secondary complication of aortic dissection or as a rare manifestation of vascular occlusive disease in specific genetic variants.
Primary Cardiovascular Pathology in Marfan Syndrome
The cardiovascular complications in Marfan syndrome arise from connective tissue defects, not atherosclerosis:
Aortic root dilation and type A aortic dissection are the leading causes of morbidity and mortality in Marfan syndrome, not coronary artery disease 1.
The underlying pathology involves mutations in the FBN1 gene encoding fibrillin-1, a glycoprotein in the extracellular matrix that affects elastic fibers in the aortic media 1.
Progressive aortic root dilation occurs in virtually all individuals with Marfan syndrome and represents the primary life-threatening cardiovascular manifestation 2.
Mechanisms of MI in Marfan Syndrome
When MI does occur in Marfan patients, it typically results from non-atherosclerotic mechanisms:
Aortic Dissection Mimicking or Causing MI
Acute aortic dissection can mimic acute myocardial infarction on electrocardiography, presenting with ST-segment changes that suggest inferoposterior wall MI 3.
Aortic dissection may extend into the coronary ostia, causing true myocardial ischemia and infarction as a mechanical complication rather than atherosclerotic disease 4, 3.
A case report documented a 28-year-old Marfan patient presenting with NSTEMI secondary to an aortic pseudoaneurysm, highlighting that chest pain in Marfan syndrome requires evaluation for aortic pathology first 4.
Rare Vascular Occlusive Disease
Patients with pathogenic ACTA2 variants (a related aortopathy gene) are at increased risk for early-onset stroke or myocardial infarction related to vascular occlusive lesions, though this is not typical FBN1-related Marfan syndrome 1.
This represents a distinct genetic subtype with different vascular pathology than classic Marfan syndrome.
Primary Myocardial Dysfunction (Not Atherosclerotic)
Emerging evidence suggests intrinsic cardiac involvement in Marfan syndrome unrelated to atherosclerosis:
Advanced imaging demonstrates primary myocardial impairment in Marfan patients, with 25% showing reduced left ventricular ejection fraction and biventricular enlargement independent of valvular disease or aortic dimensions 5.
This cardiomyopathy is usually mild, asymptomatic, and represents a primary connective tissue defect rather than ischemic heart disease 6, 5.
Increased aortic stiffness and left ventricular dysfunction occur through vascular-ventricular interaction mechanisms, not atherosclerosis 7.
Clinical Pitfalls and Diagnostic Approach
When a Marfan patient presents with chest pain, the differential diagnosis must prioritize aortic dissection over acute coronary syndrome:
Simultaneous chest X-ray and CT angiography are recommended to exclude both pneumothorax and Type A or Type B aortic dissection before assuming coronary pathology 8.
Electrocardiographic changes suggesting MI may actually represent aortic dissection with coronary involvement 3.
Assessment for hemodynamic instability (hypotension, tachycardia) is crucial as these findings suggest aortic dissection or tension pneumothorax rather than uncomplicated MI 8.
Absence of Accelerated Atherosclerosis
The major cardiovascular guidelines for Marfan syndrome focus exclusively on aortic disease, valvular complications, and arrhythmias—there is no mention of increased atherosclerotic risk or need for coronary artery disease screening in the 2022 ACC/AHA guidelines 1 or 2010 guidelines 1.
This absence in comprehensive guidelines strongly suggests that atherosclerotic coronary disease is not a recognized feature of Marfan syndrome pathophysiology.
Management Implications
Beta-blockers and angiotensin receptor blockers are prescribed to slow aortic root growth, not to prevent atherosclerotic events 1, 9.
Prophylactic aortic root replacement at ≥5.0 cm diameter prevents type A dissection and improves survival, representing the primary mortality reduction strategy 1.
Late diagnosis of Marfan syndrome is associated with unplanned aortic surgery and cardiovascular death from aortic complications, not from MI 10.